FDA Committee Supports Janssen COVID-19 Vaccine Booster By Diana Ernst, RPh Publish Date October 15, 2021
Cudetaxestat Gets Orphan Drug Status for Systemic Sclerosis By Brian Park, PharmD Publish Date October 15, 2021
FDA Panel Votes in Favor of Moderna COVID-19 Vaccine Booster for Certain Groups By Diana Ernst, RPh Publish Date October 14, 2021
REGEN-COV Gets Priority Review for COVID-19 Treatment, Prophylaxis By Brian Park, PharmD Publish Date October 14, 2021
FDA Assigns PDUFA Date for Donepezil Transdermal System By Brian Park, PharmD Publish Date October 13, 2021
Emergency Use Request Submitted for Molnupiravir for Mild to Moderate COVID-19 By Brian Park, PharmD Publish Date October 12, 2021
Gantenerumab Designated Breakthrough Therapy for Alzheimer Disease By Brian Park, PharmD Publish Date October 8, 2021
FDA Panel Votes on Maribavir for Post-Transplant CMV Infection By Brian Park, PharmD Publish Date October 8, 2021
Tezepelumab Granted Orphan Drug Status for Eosinophilic Esophagitis By Brian Park, PharmD Publish Date October 8, 2021
Data Support Upadacitinib in Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis By Brian Park, PharmD Publish Date October 7, 2021
Sofpironium Bromide Gel Promising for Primary Axillary Hyperhidrosis By Brian Park, PharmD Publish Date October 7, 2021
Pfizer-BioNTech Submit Request for Emergency Use of Pediatric COVID-19 Vaccine By Diana Ernst, RPh Publish Date October 7, 2021
Novel Sodium Phenylbutyrate Formulation Under Review for Urea Cycle Disorders By Brian Park, PharmD Publish Date October 6, 2021
AstraZeneca Seeks EUA for Long-Acting Antibody Combo for COVID-19 Prevention By Brian Park, PharmD Publish Date October 5, 2021
Posoleucel Gets Orphan Drug Status for Virus-Associated Hemorrhagic Cystitis By Brian Park, PharmD Publish Date October 5, 2021
Oral Antiviral Molnupiravir Cuts Risk of COVID-19 Hospitalization, Death By Brian Park, PharmD Publish Date October 1, 2021
Ublituximab BLA Submitted for Relapsing Forms of Multiple Sclerosis By Brian Park, PharmD Publish Date October 1, 2021
Cipaglucosidase Alfa, Miglustat Under Review for Pompe Disease By Brian Park, PharmD Publish Date September 30, 2021
Pfizer-BioNTech Submit Pediatric COVID-19 Vaccine Data for FDA Review By Brian Park, PharmD Publish Date September 28, 2021
Long-Acting Cabotegravir Gets Priority Review for HIV PrEP By Brian Park, PharmD Publish Date September 28, 2021
